Detalhe da pesquisa
1.
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Blood
; 140(5): 451-463, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605184
2.
Intrathecal hydrocortisone for treatment of children and young adults with CAR T-cell immune-effector cell-associated neurotoxicity syndrome.
Pediatr Blood Cancer
; 71(1): e30741, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897136
3.
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Blood
; 138(24): 2469-2484, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525183
4.
Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
Transfusion
; 61(4): 1041-1046, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528026
5.
Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia.
Pediatr Blood Cancer
; 68(10): e29247, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309174
6.
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement.
Pediatr Blood Cancer
; 67(4): e28149, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981407
7.
Invasive fusariosis masquerading as extramedullary disease in rapidly progressive acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 66(7): e27732, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30900813
8.
Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation.
Pediatr Blood Cancer
; 64(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27762068
9.
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
J Clin Invest
; 134(8)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376944
10.
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma.
Haematologica
; 103(5): e215-e218, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29419431
11.
Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells.
Mol Ther Methods Clin Dev
; 28: 51-61, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620075
12.
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials.
Blood Adv
; 7(18): 5566-5578, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486616
13.
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295816
14.
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.
Transplant Cell Ther
; 29(9): 574.e1-574.e10, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394115
15.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482927
16.
Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther
; 28(1): 31.e1-31.e9, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687939
17.
Fertility and CAR T-cells: Current practice and future directions.
Transplant Cell Ther
; 28(9): 605.e1-605.e8, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705177
18.
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.
Blood Adv
; 6(23): 6040-6050, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939781
19.
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.
Blood Adv
; 6(7): 2167-2182, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34920453
20.
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies.
Neuro Oncol
; 24(9): 1584-1597, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148417